{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By VICTOR FLEISCHER", "person": [{"rank": 1, "role": "reported", "firstname": "Victor", "organization": "", "lastname": "FLEISCHER"}]}, "abstract": null, "type_of_material": "News", "word_count": "917", "lead_paragraph": "The United States approach has been a failure, and a $152 billion drug merger could nudge tax-writing committees in Washington into action.", "pub_date": "2015-11-25T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Why Pfizer\u2019s Deal May Change the System of\u00a0Taxing Multinationals", "content_kicker": "Standard Deduction", "kicker": "Standard Deduction"}, "snippet": "The United States approach has been a failure, and a $152 billion drug merger could nudge tax-writing committees in Washington into action.", "multimedia": [{"height": 126, "url": "images/2015/11/25/business/db-deduction-web1/db-deduction-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/11/25/business/db-deduction-web1/db-deduction-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 395, "url": "images/2015/11/25/business/db-deduction-web1/db-deduction-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "395", "xlarge": "images/2015/11/25/business/db-deduction-web1/db-deduction-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/11/25/business/db-deduction-web1/db-deduction-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/11/25/business/db-deduction-web1/db-deduction-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/11/25/business/dealbook/why-pfizers-deal-may-change-the-system-oftaxing-multinationals.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Corporate Taxes", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Allergan Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Pfizer Inc", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Law and Legislation", "name": "subject"}], "blog": [], "_id": "56547df638f0d858aca89e3f", "source": "The New York Times"}